A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
Clinical trial NCT01641939 · TERMINATED
Trial details
- NCT number
- NCT01641939
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-03
- Primary completion
- 2015-06-30
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.